Pacesetter and Advanced Neuromodulation Systems secure grants for cardiac and neuromodulation devices.
The filing
On November 10, 2026, Advanced Neuromodulation Systems, Inc. received US patent 12788972 for dorsal root ganglia surgical leads and US patent 12788996 for systems and methods for providing digital health services. On the same date, Pacesetter, Inc. received US patents 12788992, 12788998, 12788999, and 12789000 for technologies including discriminating monomorphic tachycardia, fixation mechanisms for leadless cardiac biostimulators, implantable medical devices, and biostimulators with strain-relieved pacing elements. Pacesetter, Inc. also had application US20260355528A1 published on November 12, 2026 for an implantable medical device with a corrosion-resistant feedthrough assembly.
This filing’s full text wasn’t read for this issue, so its claims and the applicant’s background aren’t shown. Both are in the record, under Sources.